Oppenheimer Holdings Inc. shares rise 2.11% premarket after initiating coverage on KB Home and Tectonic Therapeutic.

Oppenheimer Holdings Inc. rose 2.11% in premarket trading, with the company adjusting its price target on Ligand Pharmaceuticals Incorporated, a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The company also hiked its price target on Alphabet Inc., a holding company organized around six areas of activities, including the operation of a web-based search engine (Google), development and production of home automation solutions (Nest Labs), research and development into biotechnology (Calico), research into artificial intelligence (Google X), and investment services.